Natera: Focus On Signatera And H1 2024 Results

I m Antines the minimal manufacturer of the many of the may be NicoElNino Thesis Natera, Inc. (NASDAQ:NTRA) is a diagnostic company focused on the development and commercialization of cell-free DNA (cfDNA) tests. The company's test can be grouped into three main health areas: women's health, organ health, and oncology. In terms of revenue, Natera's lead products are Panorama (a non-invasive prenatal genetic test aiming to identify altered genes in the fetus from the mom's blood sample) and Horizon (a carrie ...